This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Justin Gomme: Innovator in Heterocyclic Compounds
Introduction
Justin Gomme is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds.
Latest Patents
Justin Gomme holds a patent for "Heterocyclic compounds useful as dual ATX/CA inhibitors." This invention provides novel compounds characterized by a general formula, where specific variables are defined. The patent also includes compositions and methods for utilizing these compounds effectively.
Career Highlights
Throughout his career, Justin has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Justin has collaborated with esteemed colleagues such as Patrizio Mattei and Jérôme Hert. These partnerships have fostered innovation and have been instrumental in his research endeavors.
Conclusion
Justin Gomme's work in the field of heterocyclic compounds showcases his innovative spirit and dedication to advancing scientific knowledge. His contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile